Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine: A 24-week, randomized, placebo-con...

por Riddle, Matthew C., Forst, Thomas, Aronson, Ronnie, Sauque-Reyna, Leobardo, Souhami, Elisabeth, Silvestre, Louise, Ping, Lin, Rosenstock, Julio
Publicado 2013

Advancing Therapy in Suboptimally Controlled Basal Insulin–Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Tri...

por Rosenstock, Julio, Emral, Rifat, Sauque-Reyna, Leobardo, Mohan, Viswanathan, Trescolí, Carlos, Al Sifri, Saud, Lalic, Nebojsa, Alvarez, Agustina, Picard, Pascaline, Bonnemaire, Mireille, Demil, Nacima, McCrimmon, Rory J.
Publicado 2021

Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort

por Arellano-Campos, Olimpia, Gómez-Velasco, Donaji V., Bello-Chavolla, Omar Yaxmehen, Cruz-Bautista, Ivette, Melgarejo-Hernandez, Marco A., Muñoz-Hernandez, Liliana, Guillén, Luz E., Garduño-Garcia, Jose de Jesus, Alvirde, Ulices, Ono-Yoshikawa, Yukiko, Choza-Romero, Ricardo, Sauque-Reyna, Leobardo, Garay-Sevilla, Maria Eugenia, Malacara-Hernandez, Juan Manuel, Tusie-Luna, Maria Teresa, Gutierrez-Robledo, Luis Miguel, Gómez-Pérez, Francisco J., Rojas, Rosalba, Aguilar-Salinas, Carlos A.
Publicado 2019